After five intensive rounds of directed evolution, a leading biotech company had achieved an 8x increase in enzyme activity and a 12x increase in enzyme specificity. However, they had reached a plateau.
Fungal unspecific peroxygenases (UPOs) are highly valuable for industrial applications due to their broad substrate scope and simple catalytic mechanism, which only requires hydrogen peroxide. This eliminates the need for expensive redox partners and cofactor recycling systems, making them ideal for large-scale processes.
However, their real-world application has been limited. Since UPOs are derived from fungi, their production is challenging in bacteria —the most common and cost-effective industrial system. This difficulty has prevented them from reaching their full potential in fields like bioremediation and synthetic chemistry.
Having previously patented a set of industrially available bacterial peroxygenases (BUPOs) with our partner Gecco Biotech, we asked a critical question: could we use this data to engineer even more versatile enzymes?
To prove the concept, we initiated a collaboration with Gecco Biotech, RUG, and the University of Pavia. We selected a tyrosine hydroxylase from the literature, a bacterial peroxygenase known for its high specificity to just one substrate: tyrosine.
Our solution involved engineering this tyrosine hydroxylase; not only to improve its catalytic activity, but also to expand its substrate scope, transforming it from a highly specific enzyme into a more unspecific one. This would demonstrate the potential for optimizing BUPOs for a wide range of applications.